| Harutun Harry Urfalyan, | |
|
2037 Verdugo Blvd, Montrose, CA 91020-1626 | |
| (818) 248-8018 | |
| Not Available |
| Full Name | Harutun Harry Urfalyan |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 2037 Verdugo Blvd, Montrose, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1982188264 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 78996 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Harutun Harry Urfalyan, 1671 N Altadena Dr, Altadena, CA 91001-3622 Ph: () - | Harutun Harry Urfalyan, 2037 Verdugo Blvd, Montrose, CA 91020-1626 Ph: (818) 248-8018 |
News Archive
Boston Medical Center (BMC) has been chosen to lead an investigation aimed at developing novel approaches to prevent tuberculosis (TB). Jerrold J. Ellner, MD, chief of the section of infectious diseases at BMC and professor of medicine at the Boston University School of Medicine (BUSM), a renowned expert in the field, will serve as principal investigator (PI) on the five-year, $3 million grant funded by the National Institutes of Health (NIH).
If you're sick, traveling to a foreign land may boost your spirits, but jeopardize your health, according to a paper being presented at the American Society of Nephrology's 42nd Annual Meeting and Scientific Exposition in San Diego, CA. The findings indicate that dialysis patients who travel on vacation risk infections, anemia, and other complications that can compromise their dialysis treatments.
Exactly one year to the day after President Obama's historic decision to reverse an eight-year restriction on federally funded embryonic stem cell research, the Children's Hospital Boston Stem Cell Program today announced the development of a unique, comprehensive web site and released a candid video message from its top researchers on the current state of stem cell research to introduce the new site: stemcell.childrenshospital.org.
The experimental heart failure drug omecamtiv mecarbil reduced heart failure hospitalizations by a greater margin among patients with more severely reduced ejection fraction, a measure indicating severe impairment in the heart's pumping ability, compared with those who had moderately reduced ejection fraction, according to research presented at the American College of Cardiology's 70th Annual Scientific Session.
› Verified 3 days ago
Mania Gharibian, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2037 Verdugo Blvd, Montrose, CA 91020 Phone: 818-248-8018 | |
Zohrab Khacheryan, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2037 Verdugo Blvd, Montrose, CA 91020 Phone: 323-333-4074 | |
Nicole Ouzounian, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2037 Verdugo Blvd, Montrose, CA 91020 Phone: 818-248-8018 | |
Thuan Minh Hoang, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2037 Verdugo Blvd, Montrose, CA 91020 Phone: 818-248-8018 | |
Garo Boyajian, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2037 Verdugo Blvd, Montrose, CA 91020 Phone: 818-248-8018 | |
Erebooni Annie Aslanian, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2037 Verdugo Blvd, Montrose, CA 91020 Phone: 818-248-8018 | |
Dr. Renia Shahjahanian, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2727 Montrose Ave Apt 5, Montrose, CA 91020 Phone: 818-468-9311 |